NAFLD’s impact on liver regenerative capacity poses a pressing concern, prompting our investigation into the regenerative potential of chimeric fibroblast growth factor 21 (FGF21)/Hepatocyte Growth Factor Receptor (HGFR) within the context of NAFLD. The gene discussed is MET; the disease is metabolic dysfunction-associated steatotic liver disease.